News | Structural Heart | July 05, 2019

FEops HEARTguide Wins CSI Highlight of the Year Award

Software helps physicians evaluate device sizing and positioning pre-operatively for TAVI and left atrial appendage occlusion procedures

FEops HEARTguide Wins CSI Highlight of the Year Award

July 5, 2019 — FEops announced that FEops HEARTguide was the winning entry at CSI Frankfurt 2019 voted on by physician attendees for the Highlight of the year award in the interventional imaging category. This award celebrates promising technologies that will have the biggest impact in the field, on daily practice or on patients’ health and outlook. Cameron Dowling, M.D., St George’s, U.K., and Martin Swaans, M.D., Ph.D., St. Antonius, The Netherlands, shared their early experience with patient-specific computer simulation of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve morphology.

FEops HEARTguide, which received CE mark earlier this year, is a procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning pre-operatively using novel computational modeling and simulation technology. The current release includes workflows for TAVI and left atrial appendage occlusion (LAAO) procedures.

In addition to the Highlight of the year award, FEops HEARTguide was also starring in two best poster awards at CSI: 

  • Best poster in TAVI, commented by Dowling and focusing on the impact of FEops HEARTguide on heart team decision making for TAVI in patients with bicuspid aortic valves; and 
  • Best poster in LAA Occlusion, where A. Bavo, FEops, Belgium, presented the validation data for the LAAO workflow within FEops HEARTguide. 

Dowling stated, “This award recognizes the outstanding work undertaken by the FEops team in developing patient-specific computer simulations for structural heart interventions.”

FEops HEARTguide cloud-based procedure planning environment uses advanced personalized computational modeling and simulation to provide clinicians and medical device manufacturers with insights into the interaction between transcatheter structural heart devices and specific patient anatomy – preoperatively. The current release includes TAVI and LAAO workflows. Such insights have the power to accelerate research and development of novel device-based solutions, as well as ultimately help to improve clinical outcomes in real-world hospital settings.

Read the article "FEops Closes Financing to Commercialize TAVIguide Service"

For more information: www.feops.com

Related Content

Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Overlay Init